The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Microencapsulated chitosan nanoparticles for pulmonary protein delivery: In vivo evaluation of insulin-loaded formulations
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calvo, P., Remuñan-López, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012128907225 · Cited by 817
Formulation strategy and use of excipients in pulmonary drug delivery
Pilcer, G., & Amighi, K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.03.017 · Cited by 791
Inhaled nanoparticles—A current review
Yang, W., Peters, J. I., & Williams, R. O. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.02.011 · Cited by 666
Mechanisms of macromolecule absorption by the lungs
Patton, J. S. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00113-l · Cited by 641
Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
Fernández-Urrusuno, R., Calvo, P., Remuñán-López, C., Vila-Jato, J. L., & José Alonso, M. (1999) · Pharmaceutical Research · doi:10.1023/a:1018908705446 · Cited by 587
Self-citationDriscoll, K. E. (2000) · Toxicological Sciences · doi:10.1093/toxsci/55.1.24 · Cited by 578
Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage
Tabata, Y., & Ikada, Y. (1988) · Biomaterials · doi:10.1016/0142-9612(88)90033-6 · Cited by 538
Mucoadhesive nanoparticulate systems for peptide drug delivery
Takeuchi, H., Yamamoto, H., & Kawashima, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00120-4 · Cited by 488
Microencapsulated chitosan nanoparticles for lung protein delivery
Grenha, A., Seijo, B., & Remuñán-López, C. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.04.009 · Cited by 469
Self-citationTargeted delivery of nanoparticles for the treatment of lung diseases
Azarmi, S., Roa, W. H., & Löbenberg, R. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.006 · Cited by 440
Mucoadhesive nanoparticulate systems for peptide drug delivery.
Takéuchi, Hirofumi, Yamamoto, Y., Hiromitsu, Kawashima, & Yoshiaki (2002) · 岐阜藥科大學紀要 = The annual proceedings of Gifu College of Pharmacy · Cited by 432
Pulmonary distribution of particles given by intratracheal instillation or by aerosol inhalation
Brain, J. D., Knudson, D. E., Sorokin, S. P., & Davis, M. A. (1976) · Environmental Research · doi:10.1016/0013-9351(76)90107-9 · Cited by 416
Yamamoto, H., Kuno, Y., Sugimoto, S., Takeuchi, H., & Kawashima, Y. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.10.010 · Cited by 389
Particle engineering techniques for inhaled biopharmaceuticals
Shoyele, S. A., & Cawthorne, S. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.010 · Cited by 301
Bosquillon, C., Lombry, C., Préat, V., & Vanbever, R. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00362-x · Cited by 296
Sham, J. O.-H., Zhang, Y., Finlay, W. H., Roa, W. H., & Löbenberg, R. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.041 · Cited by 284
Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system
KRAULAND, A., & ALONSO, M. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.005 · Cited by 222
Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro
Grenha, A., Grainger, C. I., Dailey, L. A., Seijo, B., Martin, G. P., Remuñán-López, C., & Forbes, B. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.02.008 · Cited by 219
Self-citationAntitubercular inhaled therapy: opportunities, progress and challenges
Pandey, R., & Khuller, G. K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki027 · Cited by 188
Inhalable microparticles containing large payload of anti-tuberculosis drugs
Muttil, P., Kaur, J., Kumar, K., Yadav, A. B., Sharma, R., & Misra, A. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.06.006 · Cited by 173
Ungaro, F., d'Emmanuele di Villa Bianca, R., Giovino, C., Miro, A., Sorrentino, R., Quaglia, F., & La Rotonda, M. I. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.12.011 · Cited by 167
Factors influencing the deposition of inhaled particles.
Yeh, H. C., Phalen, R. F., & Raabe, O. G. (1976) · Environmental Health Perspectives · doi:10.1289/ehp.7615147 · Cited by 160
Marschütz, M. K., & Bernkop‐Schnürch, A. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00039-9 · Cited by 151
Bachelder, E. M., Beaudette, T. T., Broaders, K. E., Fréchet, J. M. J., Albrecht, M. T., Mateczun, A. J., Ainslie, K. M., Pesce, J. T., & Keane‐Myers, A. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900311x · Cited by 129
Alveolar macrophages are a primary barrier to pulmonary absorption of macromolecules
Lombry, C., Edwards, D. A., Véronique Préat, A., & Rita Vanbever, A. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00260.2003 · Cited by 126
Design of fine particles for pulmonary drug delivery
Weers, J. G., Tarara, T. E., & Clark, A. R. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.3.297 · Cited by 125
Chitosan and the mucosal delivery of biotechnology drugs
Issa, M. M., Köping‐Höggård, M., & Artursson, P. (2005) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2005.05.008 · Cited by 120
Mechanisms of alveolar protein clearance in the intact lung
Hastings, R. H., Folkesson, H. G., & Matthay, M. A. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00205.2003 · Cited by 118
Effect of particle size of dry powder mannitol on the lung deposition in healthy volunteers
Glover, W., Chan, H., Eberl, S., Daviskas, E., & Verschuer, J. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.08.013 · Cited by 106
Pritchard, J. N., Holmes, A., Evans, J. C., Evans, N., Evans, R. J., & Morgan, A. E. (1985) · Environmental Research · doi:10.1016/0013-9351(85)90025-8 · Cited by 104
Chitosan Nanoparticle-Loaded Mannitol Microspheres: Structure and Surface Characterization
Grenha, A., Seijo, B., Serra, C., & Remuñán‐López, C. (2007) · Biomacromolecules · doi:10.1021/bm061131g · Cited by 99
Self-citationSwellable microparticles as carriers for sustained pulmonary drug delivery
El-sherbiny, I. M., McGill, S. L., & Smyth, H. D. C. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22003 · Cited by 92
Pulmonary Delivery of Salmon Calcitonin Dry Powders Containing Absorption Enhancers in Rats
Kobayashi, S., Kondo, S., & Juni, K. (1996) · Pharmaceutical Research · doi:10.1023/a:1016081301369 · Cited by 85
Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs
Fiegel, J., Fu, J., & Hanes, J. S. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.02.018 · Cited by 80
Inhalation, Deposition, and Fate of Insulin and Other Therapeutic Proteins
Brain, J. D. (2007) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2007.0228 · Cited by 76
Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis.
Giosuè, S., Casarini, M., Ameglio, F., ZANGRILLI, P., Palla, M., Altieri, A. M., & Bisetti, A. (2000) · PubMed · Cited by 74
Hydrophilic solute transport across rat alveolar epithelium
Berg, M. M., Kim, K. J., Lubman, R. L., & Crandall, E. D. (1989) · Journal of Applied Physiology · doi:10.1152/jappl.1989.66.5.2320 · Cited by 55
Lombry, C., Bosquillon, C., Véronique Préat, A., & Rita Vanbever, A. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00174-8 · Cited by 46
A preliminary pharmacokinetic study of liposomal leuprolide dry powder inhaler: A technical note
Shahiwala, A., & Misra, A. R. (2005) · AAPS PharmSciTech · doi:10.1208/pt060360 · Cited by 37
Jalalipour, M., Najafabadi, A. R., Gilani, K., Esmaily, H., & Tajerzadeh, H. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21353 · Cited by 36
Beneficial effect of inhaled mannitol and cough in asthmatics with mucociliary dysfunction
Daviskas, E., Anderson, S. D., Eberl, S., & Young, I. H. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.05.019 · Cited by 31
Grainger, C. I., Alcock, R. S., Gard, T. G., Quirk, A. V., van Amerongen, G., de Swart, R. L., & Hardy, J. G. (2003) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.038 · Cited by 23
The macrophage as target or obstacle in liposome-based targeting strategies
van Rooijen, N., & Sanders, A. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00411-0 · Cited by 15
Cited by
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery
Mohammed, M., Syeda, J., Wasan, K., & Wasan, E. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9040053 · Cited by 1,362
Chitosan as biomaterial in drug delivery and tissue engineering
Ahsan, S. M., Thomas, M., Reddy, K. K., Sooraparaju, S. G., Asthana, A., & Bhatnagar, I. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.08.140 · Cited by 684
Chitosan nanoparticles: Preparation, size evolution and stability
Rampino, A., Borgogna, M., Blasi, P., Bellich, B., & Cesàro, A. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.07.034 · Cited by 622
Antimicrobial Properties of Chitosan and Chitosan Derivatives in the Treatment of Enteric Infections
Yan, D., Li, Y., Liu, Y., Li, N., Zhang, X., & Yan, C. (2021) · Molecules · doi:10.3390/molecules26237136 · Cited by 608
Metadata
- Authors
- Al-Qadi, S., Grenha, A., Carrión-Recio, D., Seijo, B., & Remuñán-López, C.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 157
- Issue
- 3
- Pages
- 383-390
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2085277747
- Cited by
- 265
- References
- 43
- FWCI
- 14.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.